

Over the past 12 months, $SNY has been mentioned 16 times by 3 distinct FinTwit voices, with the first mention appearing on 2025-07-22 and the most recent on 2026-02-12. Jacob Plieth (@jacobplieth) leads the discussion with 11 mentions, followed by Adam Feuerstein (@adamfeuerstein) with 7 mentions, and Antonio Costa (@acinvestorblog) with 1 mention. The biotech category dominates the conversation around Sanofi.
Recent discussion has centered on leadership changes at the company, with Jacob Plieth commenting on the appointment of a new CEO to replace Paul Hudson, stating the newcomer's track record "makes Paul Hudson look good." Feuerstein and Plieth have also engaged in technical discussions about Sanofi's antibody-drug conjugate (ADC) pipeline, including details about CEACAM5 ADC programs and payload mechanisms, indicating sustained interest in the company's therapeutic development efforts.
@jacobplieth (Jacob Plieth) mentions $SNY most — 11 mentions in the past 12 months.
The earliest tracked mention of $SNY in the Surfaced archive was on Jul 22, 2025.
3 FinTwit voices have mentioned $SNY 16 times in the past 12 months.
$SNY is mentioned most by Biotech voices on Surfaced.
